does hims compounded semaglutide work & Hers announces access to GLP-1 injections for as low as $99/month to U.S. military, veterans, teachers, nurses and first responders Hims & Hers investors run

Arakawa M, Mita T, Azuma K, Ebato C, Goto H, Nomiyama T, Fujitani Y, Hirose T, Kawamori R, Watada H: Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4

Exenatide, the first GLP-1 receptor agonist, was approved in 2005, followed by the development of extended-release versions such as liraglutide and semaglutide (Furman 2012)

HumeCare+ is built for someone who's already decided GLP-1 medication is worth considering but doesn't want to lose muscle along with fat, and doesn't want to guess whether their dose is doing what it's supposed to

In fact, there is a current shortage of Ozempic that is expected to last until the end of 2024 (Therapeutic Goods Administration, 2024)

For many companies, the safest path is to exit GLP-1 sales and refocus on compounds with lower regulatory and IP risk